Preventing Smoking Relapse After Total Joint Replacement Surgery
1 other identifier
interventional
21
1 country
1
Brief Summary
Hospitalization for elective knee or hip replacement surgery presents an outstanding opportunity to motivate people to quit smoking, because it provides an opportunity to encourage patients to remain smoke-free as they proactively quit to optimize their surgery outcomes. This study will conduct a comparative effectiveness trial of patients who quit smoking pre-operatively, comparing the current standard of care with a novel comprehensive relapse prevention intervention guided by Marlatt's Relapse Prevention Model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2018
CompletedFirst Posted
Study publicly available on registry
September 17, 2018
CompletedStudy Start
First participant enrolled
January 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2021
CompletedNovember 12, 2021
November 1, 2021
2 years
August 27, 2018
November 10, 2021
Conditions
Outcome Measures
Primary Outcomes (6)
Self Reported Relapse Rate for Usual Care Arm
Measured using the modified Dillman method
3 Months
Self Reported Relapse Rate for Usual Care Arm
Measured using the modified Dillman method
6 Months
Self Reported Relapse Rate for Usual Care Arm
Measured using the modified Dillman method
12 Months
Self Reported Relapse Rate for relapse prevention intervention arm
Measured using the modified Dillman method
3 Months
Self Reported Relapse Rate for relapse prevention intervention arm
Measured using the modified Dillman method
6 Months
Self Reported Relapse Rate for relapse prevention intervention arm
Measured using the modified Dillman method
12 Months
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants randomized to the Intervention Arm will receive counseling that includes: * A Visit prior to discharge * Follow up calls after discharge * Text Messaging Support * Caregiver Support
Standard treatment
ACTIVE COMPARATORPatients will receive current usual care.
Interventions
This intervention consists of 4 components: 1. Visit Prior to Discharge: counselor from research team will visit patient at hospital bedside to provide counseling 2. Follow up calls after discharge: 6 proactive counseling calls and initiate unlimited reactive calls to their counselor, at days 1,3,7,14,30,an 60 days after hospital visit 3. Text messaging support: patients will be registered in NCI's Smokefree TXT while in the hospital and will receive multiple daily messages, designed for someone who has already quit 4. Caregiver support: 10 minute training session to the caregiver on how to help patient prevent relapse by increasing self efficacy, maintaining motivation and dealing with high risk situations
Participants will receive two 10 minute counseling calls from the staff of the preoperative counseling program during the first month after the hospital discharge
Patients in both arms will be encouraged to receive NRT
Eligibility Criteria
You may qualify if:
- Patient Participants
- Received preoperative smoking cessation counseling through Orthopedic Surgery Quit Smoking Program
- Undergoing elective knee or hip arthroplasty surgery
- Have not smoked any cigarettes in the week prior to admission and carbon monoxide 4 ppm46,47
- Have a cell phone (for text messaging)
- Provide informed consent in English
- Caregiver participants:
- Age ≥ 18 years
- Be a caregiver of the patient participant
- Provide informed consent in English
You may not qualify if:
- Patients will be excluded if they used smokeless tobacco or an electronic cigarette in the last 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Sherman, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2018
First Posted
September 17, 2018
Study Start
January 15, 2019
Primary Completion
January 28, 2021
Study Completion
January 28, 2021
Last Updated
November 12, 2021
Record last verified: 2021-11